Head of Hemoglobinopathies Commercialization

About the DepartmentThe Strategy & Rare Disease (STARS) organization drives the long-term strategic direction of Novo Nordisk Inc. (NNI)/North America Operations (NAO) and leads all US commercial efforts for Novo Nordisk’s Rare Disease portfolio. The mandate of STARS is to facilitate the development and to coordinate the execution of the long-term strategy, defining a sustainable business model in US beyond a 5-year time horizon. This department serves as the insiders of the US market when informing and help shaping upstream decisions around future investments and assets. The Rare Disease portfolio includes products in the hemophilia and growth disorders therapeutic areas, new products in the pipeline, and products acquired through business development efforts in existing and new areas. The STARS team collaborates and partners with groups across NAO, Research & Early Development, Development, innovation hubs across NN, other affiliates, and global. We’re looking for individuals who are enterprise thinkers, inclusive leaders, and strong collaborators, as we embark on shaping our future.

The Position

The Hemoglobinopathies Commercialization Head is accountable to formulate, lead, align and champion the US Hemoglobinopathies commercialization approach overseeing assets for Sickle Cell and Beta Thalassemia leading the strategy for each asset as well as the portfolio to ensure success, while maintaining a deep focus on patients and stellar standards of care.

Leads and sets US strategic direction and business plans for the designated therapy area aligned to NN strategies. Informs portfolio strategy with TA-level priorities and implications. Role models an enterprise mindset while influencing functional leaders to align to the enterprise vision.

In coordination with headquarters, will develop and implement effective pre-launch plans to maximize revenue, market share and profitability goals. Has significant decision-making authority and influence on impacting revenue and profitability. Leads the assets and portfolio strategy planning processes to drive integrated customer centric strategies and programming. Significant contributor to the global strategy for the TA by working closely with global marketing and medical leaders by participating in cross-functional and global Core Commercialization Teams.

Oversight of the Hemoglobinopathies TA influencing cross-functional members including Market Access, Medical Affairs, Commercial Operations, Finance, etc. Owns the Therapeutic Area Brand Plans and drives cross-functional alignment and execution on key brand decisions, takes informed chances and full ownership/responsibility of TA decisions.

Embody NN leadership behaviors, embracing innovation, leadership over process, empowerment and the value of time.

Relationships

Reports to the Head of the Rare Disease Business Unit and is a key contributor to the Rare Disease Leadership team. The Head of Hemoglobinopathies Commercialization is the primary interface with the heads of both commercial and non-commercial functions within NNI relative to the designated Therapeutic Area, their performance and business impact.

This role will oversee the Hemoglobinopathies marketing organization and will work closely with Global Marketing, Medical Affairs, Market Access, Commercial Excellence and Strategic Partnerships and Engagement to deliver on the Hemoglobinopathies ambition.

Essential Functions

• Strategic Planning and Performance:
• Develop and execute the Hemoglobinopathies assets and portfolio strategies, aligning with overall company objectives
• Responsible for the Profit & Loss (P&L) statement for the assigned therapeutic areas
• Responsible for establishing financial performance metrics while ensuring revenue targets and profitability goals are met or exceeded post-launch
• Define key performance metrics and establish mechanisms for tracking and reporting on the effectiveness of commercial marketing strategies and initiatives

Integrated StrategyAccountable for matrixed management of dedicated functions and leading the Hemoglobinopathies portfolio with a high level of influenceResponsible for ensuring market analysis, competitor assessment, and customer experience insights to shape strategic decisions and plans with iterative adjustments as new customer or competitor insights become availableLead an integrated TA and asset strategic planning process cross-functionally across the enterprise including portfolio prioritization and alignmentFacilitate strategic trade-offs on resource allocation and budgeting across the TA based on key priorities to optimize the portfolio mix and maximize return on investment in alignment with overall enterprise portfolio

• Marketing:
• Reimagine marketing through a customer experience lens to drive a focus on human centric, insight driven strategy and execution
• Accountable for shaping and defining customer experience strategy, planning and execution across customer types including HCPs and patients in Hemaglobinopathies
• Provides leadership oversight in developing and executing the overall pre-launch and launch strategic and tactical brand plans in alignment/collaboration with global marketing
• Translating product strategy into brand-specific and customer centric experiences across channels and segments
• Oversee the development of brand vision, strategies, business plans, launch plans to drive market share, profits and impact on Hemaglobinopathies
• Translate the TA strategy into Marketing objectives / initiatives for Sickle Cell and Beta Thalassemia
• Identify market opportunities, translate opportunities into 5D offering’s scope (diagnostics, drug, device, data and digital), and drive commercialization strategies that result in a successful disease activation, product/brand uptake and utilization
• Coordinate the competitive defense, and strategic evolution of the assets
• Develop strategic approach to impact diverse communities. Identify objectives, optimal goals and key messages needed to resonate
• Embrace Rare Disease’s entrepreneurial mindset by promoting a culture of creativity and innovation including commercialization approaches, digital strategies, to maximize the potential of our medicines
• Champion an innovative mindset in strategizing and developing go-to-market models.
• Evidence based marketing: Using best in class quantitative measures to deliver desired ROI

Product evolution and development:Responsible for working with global on US-led perspective on BD&L and lifecycle managementResponsible for leading market TA aligned product launch planning and execution, ensuring successful innovative go-to-market entry and adoption, when applicableFosters strong relationships with internal teams, including Sales, Commercial Excellence, R&D, Medical Affairs, Regulatory Affairs, Market Access, Legal and Compliance to ensure alignment in product development, launch strategies, and lifecycle managementIdentify opportunities for growth, market expansion, and portfolio optimizationBuild relationships with key providers and patient thought leadersTeam Leadership and Excellence:Foster a culture of accountability, innovation, and continuous improvementDrive a culture of change agility and adaptabilityBuild and lead a high-performing commercial team, providing mentorship and guidance to ensure individual and team successResponsible for the development and coaching of general management / end to end managementFosters the professional growth and strategic acumen of Therapeutic Area leads, guiding them to navigate market complexities and achieve targeted business objectivesResponsible for setting and communicating clear individualized role expectations for each report based on position, skills, talents, and objectivesEnsure reporting personnel have strengths-based development plans (IDP), with annual goals and measurements that are consistent with the priorities of the businessRecruit, build and lead a highly effective marketing organization.

Physical Requirements

30-40% overnight travel required.

Development Of People

Supervisory. Ensure that reporting personnel have individual development plans (IDP), with annual goals and measurements that are consistent with the priorities of the business, and that interim reviews are held so that their work is focused on those priorities, and they understand their level of accountability for results and the measurement process.

Ensure that the IDP forms include completed learning and aspiration plans and are in place for all reporting personnel to enable the achievement of goals and capability to assume increased levels of responsibility. Manage the application and communication of all Novo Nordisk policies, procedures, and Novo Nordisk Way.

Qualifications

Requires a Bachelor’s degree with a minimum of 15 years’ experience with a track record of successful launch and brand leadership, preferably across a therapeutic area Master’s degree preferredExperience in Sickle Cell is preferredAbility to coordinate and activate people across multiple departments, local and global, without formal reporting linesSolid understanding of the marketplace and competition as well as market development experience, preferably within Rare DiseaseA proven inclusive leader with 5+ years of people leadership experience and capable of leading a marketing organization with progressive increase in responsibility and scope in the pharmaceutical industryStrong outside-in analytical thinking and insights orientationStrong influence skills to align groups towards common purpose and goalsResults oriented executive possessing a high sense of urgencyDemonstrated collaboration skills in leading cross-functional teamsExceptional communication skills. Capacity to articulate the TA strategies is a mustProven track record of innovative marketing accomplishments/high impact results (based on metrics/ROI)Strategic Thinking/ Planning, Execution and follow-through/problem solving skills requiredAbility to impact and influence and interact with senior business leaders and partners; interfacing with both internal and external stakeholders to facilitate business growth

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.

Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.

Location: Plainsboro, NJ, US

Posted Date: 9/29/2024